2017 Q1 Form 10-K Financial Statement

#000104396117000005 Filed on April 13, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q4 2016
Revenue $658.0K $360.0K $1.557M
YoY Change 178.81% -12.2% -19.28%
Cost Of Revenue $459.0K $290.0K $1.762M
YoY Change -9.11% -49.12% -9.18%
Gross Profit $199.0K $70.00K -$205.0K
YoY Change -173.98% -143.75% 1763.64%
Gross Profit Margin 30.24% 19.44% -13.17%
Selling, General & Admin $1.620M $1.800M $6.192M
YoY Change -4.93% 8.43% -12.23%
% of Gross Profit 814.07% 2571.43%
Research & Development $134.0K $360.0K $1.422M
YoY Change -50.37% -25.0% -23.26%
% of Gross Profit 67.34% 514.29%
Depreciation & Amortization $48.00K $160.0K $262.0K
YoY Change -42.17% 6.67% -46.42%
% of Gross Profit 24.12% 228.57%
Operating Expenses $1.754M $2.150M $7.614M
YoY Change -11.14% 0.47% -14.53%
Operating Profit -$1.555M -$2.080M -$7.819M
YoY Change -30.67% -9.57% -12.33%
Interest Expense -$160.0K $180.0K -$250.0K
YoY Change 100.0% -151.43% -73.12%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 -$1.000K
YoY Change -100.0%
Pretax Income -$1.835M -$2.110M -$8.269M
YoY Change -12.24% -20.08% -16.15%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.762M -$1.430M -$7.616M
YoY Change -46.02% -92.61% -76.89%
Net Earnings / Revenue -267.78% -397.22% -489.15%
Basic Earnings Per Share
Diluted Earnings Per Share -$19.00M -$23.83M -$152.4M
COMMON SHARES
Basic Shares Outstanding 26.87M shares 24.79M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 Q4 2016
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.00K $50.00K $50.00K
YoY Change -72.73% -88.64% -88.64%
Cash & Equivalents $59.00K $51.00K $50.00K
Short-Term Investments
Other Short-Term Assets $190.0K $13.00K $10.00K
YoY Change -62.23% -97.58% -99.6%
Inventory $15.00K $100.0K $100.0K
Prepaid Expenses $100.0K $100.0K
Receivables $279.0K $388.0K $390.0K
Other Receivables $100.0K $0.00 $0.00
Total Short-Term Assets $567.0K $552.0K $550.0K
YoY Change -73.27% -83.18% -83.23%
LONG-TERM ASSETS
Property, Plant & Equipment $127.0K $280.0K $280.0K
YoY Change -46.41% 8.11% 7.69%
Goodwill
YoY Change
Intangibles $531.0K $0.00
YoY Change -53.66% -100.0%
Long-Term Investments
YoY Change
Other Assets $4.000K $10.00K $10.00K
YoY Change -95.45% -90.48% -90.91%
Total Long-Term Assets $662.0K $290.0K $290.0K
YoY Change -55.0% -81.1% -81.17%
TOTAL ASSETS
Total Short-Term Assets $567.0K $552.0K $550.0K
Total Long-Term Assets $662.0K $290.0K $290.0K
Total Assets $1.229M $842.0K $840.0K
YoY Change -65.79% -82.52% -82.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.509M $1.084M $1.080M
YoY Change 69.84% -71.33% -71.43%
Accrued Expenses $3.398M $700.0K $700.0K
YoY Change 1.77% -81.25% -82.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $700.0K $700.0K
YoY Change
Long-Term Debt Due $7.368M $395.0K $440.0K
YoY Change 0.3% -94.8% -94.21%
Total Short-Term Liabilities $21.13M $3.012M $3.010M
YoY Change 22.27% -82.26% -82.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $4.127M $160.0K
YoY Change
Other Long-Term Liabilities $128.0K $0.00 $4.130M
YoY Change -49.8% -100.0% 525.76%
Total Long-Term Liabilities $128.0K $4.127M $4.290M
YoY Change -49.8% 1253.11% 550.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.13M $3.012M $3.010M
Total Long-Term Liabilities $128.0K $4.127M $4.290M
Total Liabilities $21.87M $7.302M $7.300M
YoY Change 15.1% -58.6% -58.62%
SHAREHOLDERS EQUITY
Retained Earnings -$227.3M -$10.85M
YoY Change 4.89% -94.92%
Common Stock $268.0K $4.000K
YoY Change 29.47% -97.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$20.64M -$6.460M -$6.460M
YoY Change
Total Liabilities & Shareholders Equity $1.229M $842.0K $840.0K
YoY Change -65.79% -82.52% -82.57%

Cashflow Statement

Concept 2017 Q1 2016 Q4 2016
OPERATING ACTIVITIES
Net Income -$1.762M -$1.430M -$7.616M
YoY Change -46.02% -92.61% -76.89%
Depreciation, Depletion And Amortization $48.00K $160.0K $262.0K
YoY Change -42.17% 6.67% -46.42%
Cash From Operating Activities -$50.00K -$2.910M -$3.550M
YoY Change -97.4% -1.02% -71.32%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$20.00K $19.00K
YoY Change -100.0% -125.0% -90.69%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.030M $27.00K
YoY Change -100.0% 1044.44% -87.67%
Cash From Investing Activities $0.00 $1.010M $1.006M
YoY Change -100.0% 494.12% -43.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $475.0K
YoY Change -94.71%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$1.000K 1.730M $2.210M
YoY Change -100.06% -75.42%
NET CHANGE
Cash From Operating Activities -$50.00K -2.910M -$3.550M
Cash From Investing Activities $0.00 1.010M $1.006M
Cash From Financing Activities -$1.000K 1.730M $2.210M
Net Change In Cash -$51.00K -170.0K -$334.0K
YoY Change -77.03% -93.86% -79.13%
FREE CASH FLOW
Cash From Operating Activities -$50.00K -$2.910M -$3.550M
Capital Expenditures $0.00 -$20.00K $19.00K
Free Cash Flow -$50.00K -$2.890M -$3.569M
YoY Change -97.43% -4.3% -71.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0001043961
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26868062 shares
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016Q2 dei Entity Public Float
EntityPublicFloat
18600000 USD
CY2016 dei Entity Registrant Name
EntityRegistrantName
TRANSGENOMIC INC
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 tbio Accounts Receivable General Payment Terms1
AccountsReceivableGeneralPaymentTerms1
P30D
CY2015Q4 tbio Accrued Stock Issuance Cost
AccruedStockIssuanceCost
0 USD
CY2016Q4 tbio Accrued Stock Issuance Cost
AccruedStockIssuanceCost
58000 USD
CY2015 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
3466841 shares
CY2016 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
3055555 shares
CY2013Q1 tbio Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Price Per Share
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsPricePerShare
9.00
CY2012Q1 tbio Classof Warrantor Right Exercise Term1
ClassofWarrantorRightExerciseTerm1
P5Y
CY2015 tbio Classof Warrantor Right Numberof Issued Warrants Expired
ClassofWarrantorRightNumberofIssuedWarrantsExpired
431027 shares
CY2016 tbio Defined Contribution Plan Employer Matching Contribution Percentof Employees Gross Pay First Three Percentageof Contributions
DefinedContributionPlanEmployerMatchingContributionPercentofEmployeesGrossPayFirstThreePercentageofContributions
0.03
CY2016 tbio Defined Contribution Plan Employer Matching Contribution Percentof Employees Gross Pay Next Two Percentageof Contributions
DefinedContributionPlanEmployerMatchingContributionPercentofEmployeesGrossPayNextTwoPercentageofContributions
0.02
CY2016 tbio Defined Contribution Plan Employer Matching Contribution Percentof Match First Three Percentageof Contributions
DefinedContributionPlanEmployerMatchingContributionPercentofMatchFirstThreePercentageofContributions
1
CY2016 tbio Defined Contribution Plan Employer Matching Contribution Percentof Match Next Two Percentageof Contributions
DefinedContributionPlanEmployerMatchingContributionPercentofMatchNextTwoPercentageofContributions
0.5
CY2016Q4 tbio Delinquent Accounts Payable
DelinquentAccountsPayable
600000 USD
CY2015 tbio Effective Income Tax Reconciliation Capitalized Transaction Cost
EffectiveIncomeTaxReconciliationCapitalizedTransactionCost
0 USD
CY2016 tbio Effective Income Tax Reconciliation Capitalized Transaction Cost
EffectiveIncomeTaxReconciliationCapitalizedTransactionCost
244000 USD
CY2016 tbio Fair Value Assumptions Numberof Independent Simulation
FairValueAssumptionsNumberofIndependentSimulation
10 simulation
CY2016 tbio Fair Value Assumptions Percentage Of Simulated Equity Values Below Down Round Financing Cut Off Point
FairValueAssumptionsPercentageOfSimulatedEquityValuesBelowDownRoundFinancingCutOffPoint
0.25
CY2016 tbio Fair Value Assumptions Simulation Period
FairValueAssumptionsSimulationPeriod
P6M
CY2015Q4 tbio Furniture Fixtures And Leasehold Improvements Gross
FurnitureFixturesAndLeaseholdImprovementsGross
1565000 USD
CY2016Q4 tbio Furniture Fixtures And Leasehold Improvements Gross
FurnitureFixturesAndLeaseholdImprovementsGross
1565000 USD
CY2015 tbio Gain Loss On Stock Warrants Revaluation
GainLossOnStockWarrantsRevaluation
-205000 USD
CY2016 tbio Gain Loss On Stock Warrants Revaluation
GainLossOnStockWarrantsRevaluation
788000 USD
CY2015 tbio Income Tax Reconciliation Liability Warrants
IncomeTaxReconciliationLiabilityWarrants
70000 USD
CY2016 tbio Income Tax Reconciliation Liability Warrants
IncomeTaxReconciliationLiabilityWarrants
-268000 USD
CY2015 tbio Income Tax Reconciliation Miscellaneous Permanent Differences
IncomeTaxReconciliationMiscellaneousPermanentDifferences
163000 USD
CY2016 tbio Income Tax Reconciliation Miscellaneous Permanent Differences
IncomeTaxReconciliationMiscellaneousPermanentDifferences
6000 USD
CY2015 tbio Income Tax Reconciliation Net Operating Loss Carryforward Expiration And Or Adjustment
IncomeTaxReconciliationNetOperatingLossCarryforwardExpirationAndOrAdjustment
-187000 USD
CY2016 tbio Income Tax Reconciliation Net Operating Loss Carryforward Expiration And Or Adjustment
IncomeTaxReconciliationNetOperatingLossCarryforwardExpirationAndOrAdjustment
25000 USD
CY2015 tbio Initial Fair Valueof Warrants Issued
InitialFairValueofWarrantsIssued
0 USD
CY2016 tbio Initial Fair Valueof Warrants Issued
InitialFairValueofWarrantsIssued
1827000 USD
CY2015 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-724000 USD
CY2016 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-1038000 USD
CY2015 tbio Inventory Additions
InventoryAdditions
63000 USD
CY2016 tbio Inventory Additions
InventoryAdditions
0 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiring In Eight Years
OperatingLossCarryForwardExpiringInEightYears
17390000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiring In Eleven Years
OperatingLossCarryForwardExpiringInElevenYears
3238000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiring In Fourteen Years
OperatingLossCarryForwardExpiringInFourteenYears
2784000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiring In Nine Years
OperatingLossCarryForwardExpiringInNineYears
8153000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiring In Nineteen Years
OperatingLossCarryForwardExpiringInNineteenYears
15147000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiring In Seven Years
OperatingLossCarryForwardExpiringInSevenYears
16173000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiring In Seventeen Years
OperatingLossCarryForwardExpiringInSeventeenYears
12097000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiring In Six Years
OperatingLossCarryForwardExpiringInSixYears
16862000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiring In Ten Years
OperatingLossCarryForwardExpiringInTenYears
6792000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiring In Thirteen Years
OperatingLossCarryForwardExpiringInThirteenYears
591000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiring In Twelve Years
OperatingLossCarryForwardExpiringInTwelveYears
1272000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiring In Twenty Years
OperatingLossCarryForwardExpiringInTwentyYears
23499000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiringin Eighteen Years
OperatingLossCarryForwardExpiringinEighteenYears
7591000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiringin Five Years
OperatingLossCarryForwardExpiringinFiveYears
8228000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiringin Four Years
OperatingLossCarryForwardExpiringinFourYears
9662000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiringin Sixteen Years
OperatingLossCarryForwardExpiringinSixteenYears
8358000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiringin Three Years
OperatingLossCarryForwardExpiringinThreeYears
8181000 USD
CY2016Q4 tbio Operating Loss Carry Forward Expiringin Two Years
OperatingLossCarryForwardExpiringinTwoYears
1838000 USD
CY2015 tbio Other Income Expense
OtherIncomeExpense
-943000 USD
CY2016 tbio Other Income Expense
OtherIncomeExpense
-450000 USD
CY2015Q4 tbio Other Liabilities Payablefor Settlementof Warrant Conversion
OtherLiabilitiesPayableforSettlementofWarrantConversion
0 USD
CY2016Q4 tbio Other Liabilities Payablefor Settlementof Warrant Conversion
OtherLiabilitiesPayableforSettlementofWarrantConversion
462000 USD
CY2012Q1 tbio Payments Of Stock Issuance Costs Reduction To Equity
PaymentsOfStockIssuanceCostsReductionToEquity
1500000 USD
CY2012Q1 tbio Paymentsof Stock Issuance Costs Percentageof Gross Offering Proceeds
PaymentsofStockIssuanceCostsPercentageofGrossOfferingProceeds
0.07
CY2012Q1 tbio Paymentsof Stock Issuance Costs Warrant Right To Purchase Common Stock Shares
PaymentsofStockIssuanceCostsWarrantRightToPurchaseCommonStockShares
31666 shares
CY2012Q1 tbio Paymentsof Stock Issuance Costs Warrant Right To Purchase Common Stock Shares Percentageof Sharesin Offering
PaymentsofStockIssuanceCostsWarrantRightToPurchaseCommonStockSharesPercentageofSharesinOffering
0.02
CY2015Q2 tbio Principal Amount Outstandingof Loans Initial Prepayment
PrincipalAmountOutstandingofLoansInitialPrepayment
148000 USD
CY2010Q4 tbio Proceedsfromissuanceofcommonstockandconvertiblenotes
Proceedsfromissuanceofcommonstockandconvertiblenotes
6000000 USD
CY2015 tbio Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision
ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision
67000 USD
CY2016 tbio Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision
ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision
72000 USD
CY2012Q1 tbio Stock Issuance Costs Reimbursable Expenses
StockIssuanceCostsReimbursableExpenses
125000 USD
CY2016Q4 tbio Working Capital Deficiency
WorkingCapitalDeficiency
-19300000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3781000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6541000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
264000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
225000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3734000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3546000 USD
CY2016Q4 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
200000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6899000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7013000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
10000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
200403000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
205877000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
1167000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
644000 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
82000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
20000 USD
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
87000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
140000 USD
CY2015 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2016 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
19000 USD
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 USD
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000 USD
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9963886 shares
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8265584 shares
CY2015Q4 us-gaap Assets
Assets
4816000 USD
CY2016Q4 us-gaap Assets
Assets
1259000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
3282000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
495000 USD
CY2015Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1987000 USD
CY2016Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
31000 USD
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
1000 USD
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
1000 USD
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
0 USD
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
1000 USD
CY2015 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
CY2016 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1609000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
444000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110000 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1165000 USD
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-334000 USD
CY2015 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
2210000 USD
CY2016 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
1047000 USD
CY2015 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-4800000 USD
CY2016 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
1405000 USD
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.86
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.56
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.25
CY2016Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.25
CY2012Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
15.00
CY2013Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
12.96
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.73
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.86
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.56
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
9.59
CY2015Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.50
CY2014Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1309785 shares
CY2015Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1881396 shares
CY2015Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1387685 shares
CY2016Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1387685 shares
CY2012Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
948333 shares
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
691656 shares
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1097600 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1212665 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1309785 shares
CY2015Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1881396 shares
CY2015Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1483161 shares
CY2015Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2188177 shares
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6696287 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13915691 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26446927 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13915691 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26446927 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
139000 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
264000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33284000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7616000 USD
CY2015 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
CY2016 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
199000 USD
CY2015 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1940000 USD
CY2016 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1762000 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 USD
CY2015Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
7596000 USD
CY2016Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
7814000 USD
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2015 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1012000 USD
CY2016 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
807000 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 USD
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
50000 USD
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0 USD
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
217000 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
170000 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
52952000 USD
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
61310000 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
50000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
51449000 USD
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
60276000 USD
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
585000 USD
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
116000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
918000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
918000 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
52902000 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
61310000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
50000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0 USD
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
400000 USD
CY2016 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 USD
CY2015 us-gaap Depreciation
Depreciation
200000 USD
CY2016 us-gaap Depreciation
Depreciation
100000 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
489000 USD
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
262000 USD
CY2015 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
-3130000 USD
CY2016 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
4475000 USD
CY2016 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
4475000 USD
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.78
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
435000 USD
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
0 USD
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
321000 USD
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
224000 USD
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y0M1D
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1444000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
905000 USD
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
100000 USD
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
205000 USD
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-788000 USD
CY2015 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2016 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
274000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
343000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
100000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
100000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
100000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
100000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
100000 USD
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-26000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1170000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
562000 USD
CY2015 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2016 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2015 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-14000 USD
CY2016 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-199000 USD
CY2015 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-14000 USD
CY2016 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-199000 USD
CY2015 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
6900000 USD
CY2015 us-gaap Gross Profit
GrossProfit
-11000 USD
CY2016 us-gaap Gross Profit
GrossProfit
-205000 USD
CY2015Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
6200000 USD
CY2015Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2015Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
6200000 USD
CY2016 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
304000 USD
CY2015Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
7000000 USD
CY2015 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-9862000 USD
CY2016 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-8269000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9862000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8269000 USD
CY2015 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-23092000 USD
CY2016 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
653000 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3842000 USD
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3106000 USD
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3449000 USD
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2812000 USD
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-119000 USD
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
0 USD
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-320000 USD
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-301000 USD
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-365000 USD
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3085000 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-133000 USD
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
33000 USD
CY2015 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
70000 USD
CY2016 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
47000 USD
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
113000 USD
CY2016 us-gaap Interest Paid
InterestPaid
0 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
50000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
24000 USD
CY2015Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
100000 USD
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
100000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
17636000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
20609000 USD
CY2015 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1773000 USD
CY2016 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-811000 USD
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
663000 USD
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-432000 USD
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1170000 USD
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
562000 USD
CY2015 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 USD
CY2016 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
467000 USD
CY2015 us-gaap Interest Paid
InterestPaid
493000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4816000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1259000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16981000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19824000 USD
CY2015Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
264000 USD
CY2016Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7596000 USD
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7814000 USD
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
7814000 USD
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2015Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
5593000 USD
CY2016Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
5592000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8991000 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2210000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1787000 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1006000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-423000 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-41000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12378000 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3550000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7578000 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4955000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-32954000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-3264000 USD
us-gaap Net Income Loss
NetIncomeLoss
-4261000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6187000 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-7616000 USD
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-34278000 USD
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3657000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4654000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6580000 USD
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8009000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2016 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2015 us-gaap Operating Expenses
OperatingExpenses
8908000 USD
CY2016 us-gaap Operating Expenses
OperatingExpenses
7614000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-8919000 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-7819000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1318000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
226000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
244000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
239000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
235000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
230000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
144000 USD
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000 USD
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000 USD
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
167856000 USD
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
537000 USD
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
105000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
105000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
58000 USD
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-330000 USD
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1068000 USD
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1529000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
305000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
203000 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 USD
CY2015Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
200000 USD
CY2015 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
219000 USD
CY2016 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
27000 USD
CY2012Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1330000 USD
CY2016 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
219000 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
204000 USD
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19000 USD
CY2015 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1324000 USD
CY2016Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
393000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
393000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
393000 USD
CY2016 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
393000 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4029502 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
214705 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4029502 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
214705 shares
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
40000 USD
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
2000 USD
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
200000 USD
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
100000 USD
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8977000 USD
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
475000 USD
CY2015 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
CY2016 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1781000 USD
CY2015Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3000000 USD
CY2015 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
923000 USD
CY2016 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
500000 USD
CY2015 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2016 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
5000 USD
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2016 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
7000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7158000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7157000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
259000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
144000 USD
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
67000 USD
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
72000 USD
CY2016Q4 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
100000 USD
CY2015 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
35000 USD
CY2016 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
3000 USD
CY2015 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
874000 USD
CY2016 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
550000 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1853000 USD
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1422000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-213412000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-225493000 USD
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
1929000 USD
CY2016 us-gaap Sales Revenue Net
SalesRevenueNet
1557000 USD
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7055000 USD
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6192000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
611000 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
52000 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
720128 shares
CY2013Q1 us-gaap Share Price
SharePrice
6.00
CY2015Q3 us-gaap Share Price
SharePrice
1.42
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2015 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2016 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1383333 shares
CY2015Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1500000 shares
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
345000 USD
CY2016Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
89000 USD
CY2015 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 USD
CY2016 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
89000 USD
CY2013Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8300000 USD
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
506000 USD
CY2015 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
8970000 USD
CY2016 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
153000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
6553000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-12820000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-19350000 USD
CY2015Q3 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
800000 USD
CY2015 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 USD
CY2016 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 USD
CY2015Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
100000 USD
CY2015Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
350000 USD
CY2016Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
582000 USD
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12321739 shares
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20323333 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21060387 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21896943 shares
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22689831 shares
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. In addition, estimates and assumptions associated with the determination of the fair value of certain assets and related impairments require considerable judgment by management. The key estimates included in the consolidated financial statements include stock option valuations, goodwill and intangible valuations, accounts receivable and inventory valuations, warrant valuations and contractual allowances. Actual results could differ from the estimates and assumptions used in preparing these consolidated financial statements.</font></div></div>

Files In Submission

Name View Source Status
0001043961-17-000005-index-headers.html Edgar Link pending
0001043961-17-000005-index.html Edgar Link pending
0001043961-17-000005.txt Edgar Link pending
0001043961-17-000005-xbrl.zip Edgar Link pending
ex31restatedcertificateo.htm Edgar Link pending
ex31restatedcertificateo001.jpg Edgar Link pending
ex31restatedcertificateo002.jpg Edgar Link pending
ex31restatedcertificateo003.jpg Edgar Link pending
ex31restatedcertificateo004.jpg Edgar Link pending
ex31restatedcertificateo005.jpg Edgar Link pending
ex31restatedcertificateo006.jpg Edgar Link pending
ex31restatedcertificateo007.jpg Edgar Link pending
ex31restatedcertificateo008.jpg Edgar Link pending
ex31restatedcertificateo009.jpg Edgar Link pending
ex31restatedcertificateo010.jpg Edgar Link pending
ex31restatedcertificateo011.jpg Edgar Link pending
ex31restatedcertificateo012.jpg Edgar Link pending
ex31restatedcertificateo013.jpg Edgar Link pending
ex31restatedcertificateo014.jpg Edgar Link pending
ex31restatedcertificateo015.jpg Edgar Link pending
ex31restatedcertificateo016.jpg Edgar Link pending
ex31restatedcertificateo017.jpg Edgar Link pending
ex31restatedcertificateo018.jpg Edgar Link pending
ex31restatedcertificateo019.jpg Edgar Link pending
ex31restatedcertificateo020.jpg Edgar Link pending
ex31restatedcertificateo021.jpg Edgar Link pending
ex31restatedcertificateo022.jpg Edgar Link pending
ex31restatedcertificateo023.jpg Edgar Link pending
ex31restatedcertificateo024.jpg Edgar Link pending
ex31restatedcertificateo025.jpg Edgar Link pending
ex31restatedcertificateo026.jpg Edgar Link pending
ex31restatedcertificateo027.jpg Edgar Link pending
ex31restatedcertificateo028.jpg Edgar Link pending
ex31restatedcertificateo029.jpg Edgar Link pending
ex31restatedcertificateo030.jpg Edgar Link pending
ex31restatedcertificateo031.jpg Edgar Link pending
ex31restatedcertificateo032.jpg Edgar Link pending
ex31restatedcertificateo033.jpg Edgar Link pending
ex31restatedcertificateo034.jpg Edgar Link pending
ex31restatedcertificateo035.jpg Edgar Link pending
ex31restatedcertificateo036.jpg Edgar Link pending
ex31restatedcertificateo037.jpg Edgar Link pending
ex31restatedcertificateo038.jpg Edgar Link pending
ex31restatedcertificateo039.jpg Edgar Link pending
ex31restatedcertificateo040.jpg Edgar Link pending
ex31restatedcertificateo041.jpg Edgar Link pending
ex31restatedcertificateo042.jpg Edgar Link pending
ex31restatedcertificateo043.jpg Edgar Link pending
ex31restatedcertificateo044.jpg Edgar Link pending
ex31restatedcertificateo045.jpg Edgar Link pending
ex31restatedcertificateo046.jpg Edgar Link pending
ex31restatedcertificateo047.jpg Edgar Link pending
ex31restatedcertificateo048.jpg Edgar Link pending
ex31restatedcertificateo049.jpg Edgar Link pending
ex31restatedcertificateo050.jpg Edgar Link pending
ex31restatedcertificateo051.jpg Edgar Link pending
ex31restatedcertificateo052.jpg Edgar Link pending
ex31restatedcertificateo053.jpg Edgar Link pending
ex31restatedcertificateo054.jpg Edgar Link pending
ex31restatedcertificateo055.jpg Edgar Link pending
ex31restatedcertificateo056.jpg Edgar Link pending
ex31restatedcertificateo057.jpg Edgar Link pending
ex31restatedcertificateo058.jpg Edgar Link pending
ex31restatedcertificateo059.jpg Edgar Link pending
ex31restatedcertificateo060.jpg Edgar Link pending
ex31restatedcertificateo061.jpg Edgar Link pending
ex31restatedcertificateo062.jpg Edgar Link pending
ex31restatedcertificateo063.jpg Edgar Link pending
ex31restatedcertificateo064.jpg Edgar Link pending
ex31restatedcertificateo065.jpg Edgar Link pending
ex31restatedcertificateo066.jpg Edgar Link pending
ex31restatedcertificateo067.jpg Edgar Link pending
ex31restatedcertificateo068.jpg Edgar Link pending
ex31restatedcertificateo069.jpg Edgar Link pending
ex31restatedcertificateo070.jpg Edgar Link pending
ex31restatedcertificateo071.jpg Edgar Link pending
ex31restatedcertificateo072.jpg Edgar Link pending
ex31restatedcertificateo073.jpg Edgar Link pending
ex31restatedcertificateo074.jpg Edgar Link pending
ex31restatedcertificateo075.jpg Edgar Link pending
ex31restatedcertificateo076.jpg Edgar Link pending
ex31restatedcertificateo077.jpg Edgar Link pending
ex31restatedcertificateo078.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbio-20161231.xml Edgar Link completed
tbio-20161231.xsd Edgar Link pending
tbio-20161231x10krev1.htm Edgar Link pending
tbio-20161231_cal.xml Edgar Link unprocessable
tbio-20161231_def.xml Edgar Link unprocessable
tbio-20161231_lab.xml Edgar Link unprocessable
tbio-20161231_pre.xml Edgar Link unprocessable
tbio-ex211_20161231x10k.htm Edgar Link pending
tbio-ex231_20161231x10k.htm Edgar Link pending
tbio-ex232_20161231x10k.htm Edgar Link pending
tbio-ex311_20161231x10k.htm Edgar Link pending
tbio-ex321_20161231x10k.htm Edgar Link pending